# A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management

> **NCT05062902** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **HillMed Inc.** · enrollment: 46 (estimated)

## Conditions studied

- Interstitial Cystitis
- Chronic Pain
- Pelvic Floor; Relaxation
- Pelvic Floor Disorders

## Interventions

- **DEVICE:** High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device
- **DRUG:** Botulinum Neurotoxin

## Key facts

- **NCT ID:** NCT05062902
- **Lead sponsor:** HillMed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-08-15
- **Final completion:** 2027-12-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062902, "A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05062902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*